DreaMed Advisor Pro

DEVICE4 trials

Sponsors

Rabin Medical Center, Yale University

Conditions

Type 1 DiabetesType 1 Diabetes MellitusType1 Diabetes MellitusType1diabetes

Unknown Phase

Evaluation of the Dreamed Advisor Pro for Automated Insulin Pump Setting Adjustments in Children and Adolescents With Type 1 Diabetes- The Advice4U Pro Study

CompletedNCT03003806

Rabin Medical CenterType1 Diabetes Mellitus

Start: 2017-10-02End: 2019-11-10Updated: 2019-12-27

The Advisor Pro Direct Study

TerminatedNCT03774069

Rabin Medical CenterType 1 Diabetes Mellitus

Start: 2020-12-01End: 2023-12-01Updated: 2025-11-19

Use of Insulin Adjustment Device DreaMed Advisor Pro During Routine Clinical Use for Subjects With Diabetes Type 1

CompletedNCT04271228

Rabin Medical CenterType 1 Diabetes

Start: 2020-02-15End: 2022-01-19Updated: 2024-03-26

Real World Evaluation of Advisor Pro in Clinical Practice

WithdrawnNCT04904718

Yale UniversityType1diabetes

Start: 2021-12-31End: 2021-12-31Updated: 2022-01-05

Related Papers

Insulin dose optimization using an automated artificial intelligence-based decision support system in youths with type 1 diabetes.

2020-09-09135 citations